Anti-TNPO3 antibody [3152C2a]
| Name | Anti-TNPO3 antibody [3152C2a] |
|---|---|
| Supplier | Abcam |
| Catalog | ab54353 |
| Prices | $401.00 |
| Sizes | 50 µg |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG2b |
| Clone | 3152C2a |
| Applications | FC WB DB IHC-P ICC/IF ICC/IF |
| Species Reactivities | Mouse, Human |
| Antigen | Recombinant fragment (Human) from near the N terminus |
| Description | Mouse Monoclonal |
| Gene | TNPO3 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
![Anti-TNPO3 antibody [3152C2a] (ab54353) at 1/100 dilution + HeLa whole cell lysate at 25 µgSecondaryanti Mouse IgG at 1/2500 dilution](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/12935_ab54353%2520HeLa.jpg)
Anti-TNPO3 antibody [3152C2a] (ab54353) at 1/100 dilution + HeLa whole cell lysate at 25 µgSecondaryanti Mouse IgG at 1/2500 dilution
![Anti-TNPO3 antibody [3152C2a] (ab54353) at 1/50 dilution + NIH3T3 whole cell lysate at 25 µgSecondaryanti Mouse IgG at 1/2500 dilution](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/12936_ab54353%2520NIH.jpg)
Anti-TNPO3 antibody [3152C2a] (ab54353) at 1/50 dilution + NIH3T3 whole cell lysate at 25 µgSecondaryanti Mouse IgG at 1/2500 dilution
IHC image of ab54353 staining in human normal cervix formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab54353, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
![Overlay histogram showing HeLa cells stained with ab54353 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab54353, 1µg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 80% methanol/permeabilized in 0.1% PBS-Tween used under the same conditions.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/12938_TNPO3-Primary-antibodies-ab54353-3.jpg)
Overlay histogram showing HeLa cells stained with ab54353 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab54353, 1µg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 80% methanol/permeabilized in 0.1% PBS-Tween used under the same conditions.
Product References
Beta-like importins mediate the nuclear translocation of mitogen-activated - Beta-like importins mediate the nuclear translocation of mitogen-activated
Zehorai E, Seger R. Mol Cell Biol. 2014 Jan;34(2):259-70.
Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin - Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin
Melia MJ, Kubota A, Ortolano S, Vilchez JJ, Gamez J, Tanji K, Bonilla E, Palenzuela L, Fernandez-Cadenas I, Pristoupilova A, Garcia-Arumi E, Andreu AL, Navarro C, Hirano M, Marti R. Brain. 2013 May;136(Pt 5):1508-17.
HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore - HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore
Ocwieja KE, Brady TL, Ronen K, Huegel A, Roth SL, Schaller T, James LC, Towers GJ, Young JA, Chanda SK, Konig R, Malani N, Berry CC, Bushman FD. PLoS Pathog. 2011 Mar;7(3):e1001313.
The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 - The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1
Matreyek KA, Engelman A. J Virol. 2011 Aug;85(15):7818-27.
Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 - Transportin 3 promotes a nuclear maturation step required for efficient HIV-1
Zhou L, Sokolskaja E, Jolly C, James W, Cowley SA, Fassati A. PLoS Pathog. 2011 Aug;7(8):e1002194.
Pigment epithelium-derived factor (PEDF) interacts with transportin SR2, and - Pigment epithelium-derived factor (PEDF) interacts with transportin SR2, and
Anguissola S, McCormack WJ, Morrin MA, Higgins WJ, Fox DM, Worrall DM. PLoS One. 2011;6(10):e26234.
The cargo-binding domain of transportin 3 is required for lentivirus nuclear - The cargo-binding domain of transportin 3 is required for lentivirus nuclear
Logue EC, Taylor KT, Goff PH, Landau NR. J Virol. 2011 Dec;85(24):12950-61.
Flexible use of nuclear import pathways by HIV-1. - Flexible use of nuclear import pathways by HIV-1.
Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN. Cell Host Microbe. 2010 Mar 18;7(3):221-33.
The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection - The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection
Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A. J Virol. 2010 Jan;84(1):397-406.